Observational studyCardiovascular diabetology2021

Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence.

Meir Schechter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.